Wen Lv

Wen Lv


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 April 2019 in BMC Neurology
Verified
Journal Article
Open access
PDF file
LLLei-Qing Li
Lei-Qing Li
XXXiao-Yan Xu
Xiao-Yan Xu
WLWenyu Li
Wenyu Li
XHXing-Yue Hu
Xing-Yue Hu
WLWen Lv
Wen Lv
Serum triiodothyronine (T3) concentration was reported to be associated with the prognosis after acute ischemic stroke. The aim of this study was to evaluate the effect of age on the prognostic value of thyroid-related hormones after an acute ischemic stroke. This was a retrospective study involving the review of 1072 ischemic stroke patients who had been consecutively admitted to the hospital within 72 h of symptom onset. Total triiodothyronine (T3), total thyroxine (T4), free T3, free T4, and thyroid-stimulating hormone (TSH) were assessed to determine their values for predicting functional outcome at the first follow-up clinic visits, which usually occurred 2 to 4 weeks after discharge from the hospital. A total of 768 patients were finally included in the study and divided into two age groups: a younger group (age < 65 years) and an older group (age ≥ 65 years). On univariate analysis, four factors—lower total T3, free T3 concentrations, higher scores on the National Institute of Health Stroke Scale (NIHSS) and the presence of atrial fibrillation—were associated with poor functional outcomes in both groups. In addition, older age, female gender, higher free T4, and lower TSH levels were also associated with poor function in the older group. On multiple logistic regression analysis, higher NIHSS scores (odds ratio [OR] =1.95; 95% confidence interval [CI], 1.66–2.30; P ≤ .001) and lower total T3 concentrations (OR = 0.06; 95% CI, 0.01–0.68; P = .024) remained independently associated with poor functional outcome in the older group. However, the independent association with poor function of lower total T3 was not confirmed in the younger group. The prognostic value of low total T3 is age-associated and more meaningful in an older population.

15 March 2022 in Internal Medicine
Verified
Journal Article
Open access
PDF file
PXPing Xia
Ping Xia
FXFei Xie
Fei Xie
ZZZhi-Jie Zhou
Zhi-Jie Zhou
WLWen Lv
Wen Lv
The patient had suffered from both proximal and distal limb weakness since her early childhood, without the involvement of ocular or respiratory muscles. Repetitive nerve stimulation (RNS) at 3 Hz showed significant decrement in the area and amplitude of the compound muscle action potential (CMAP) on the right abductor digiti minimi (26%) and trapezius (17%). Whole-exon sequencing revealed two novel heterozygous mutations (p.Q1406Rfs*29 and p.R1521H) in the LG1 domain of agrin, which were deemed likely pathogenic for congenital myasthenic syndromes (CMS) according to a bioinformatics analysis. The patient showed remarkable improvement after treatment with salbutamol. This case expanded the mutation spectrum of AGRN.

22 April 2025 in Neurological Sciences
Verified
Journal Article
Closed access
PDF file
LCLili Chen
Lili Chen
SLShuang Li
Shuang Li
FXFei Xie
Fei Xie
XHXingyue Hu
Xingyue Hu
WLWen Lv
Wen Lv

14 June 2019 in BMJ Open
Verified
Journal Article
Open access
PDF file
ZJZheng Jin
Zheng Jin
YWYaping Wei
Yaping Wei
HLHuapeng Lin
Huapeng Lin
HHHaitao Huang
Haitao Huang
WLWen Lv
Wen Lv
XZXiaofeng Zhang
Xiaofeng Zhang
Introduction Current evidence supporting the utility of endoscopic ultrasound-guided biliary drainage (EUS-BD) as a first-line treatment option for malignant biliary obstruction (MBO) is limited. We plan to provide a systematic review and meta-analysis to compare the performance of EUS-BD and endoscopic retrograde cholangiopancreatography-guided biliary drainage (ERCP-BD) as primary palliation of MBO. Methods and analysis Randomised controlled trials evaluating EUS-BD versus ERCP-BD in primary drainage of MBO will be searched in MEDLINE, EMBASE, Web of Science, the Cochrane Library, ClinicalTrials.gov and Google Scholar, from database inception to 31 October 2018. Data on study design, participant characteristics, intervention details and outcomes will be extracted. Primary outcomes to be assessed are technical and clinical success. Secondary outcomes include adverse events, stent patency, stent dysfunction, reinterventions, procedure duration and overall survival. Study quality will be assessed using the Cochrane Risk of Bias Tool. Meta-analysis will be performed using RevMan V.5.3 statistical software. Data will be combined with a random effect model. The results will be presented as a risk ratio for dichotomous data, weighted mean difference for continuous data and HR for time-to-event data. Publication bias will be visualised using funnel plots. Ethics and dissemination This study will not use primary data, and therefore, formal ethical approval is not required. The findings will be disseminated through peer-reviewed journals and committee conferences. PROSPERO registration number CRD42018117040

2 May 2026 in Behavioural Brain Research
Verified
Journal Article
Closed access
WZWenying Zhang
Wenying Zhang
XXXiaoting Xie
Xiaoting Xie
FZFei Zhong
Fei Zhong
WLWen Lv
Wen Lv
HLHSIN-YI LAI
HSIN-YI LAI
CHCong Huang
Cong Huang